Longevity Diagnostics
Democratizing advanced health diagnostics with comprehensive biomarker panels, environmental toxin detection, and personalized longevity insights for everyone.
What is AgeQuant?
Lowering the Barrier to Longevity Testing
Our mission with AgeQuant is to make advanced longevity biomarker testing accessible to everyone. We're building a platform that brings cutting-edge diagnostics out of research labs and into everyday healthcare, starting with key aging and inflammation markers.
Beyond Basic Panels
We go far beyond standard blood tests to measure aging biomarkers, inflammatory markers, and metabolic health indicators.
Environmental Insights
First-of-its-kind testing for microplastics and environmental toxins that impact your healthspan.
Personalized Action
AI-powered analysis provides personalized recommendations to optimize your health trajectory.
Current Testing Capabilities
NAD+ Metabolism
Comprehensive assessment of NAD+ levels to evaluate cellular energy production and aging status[9].
- • NAD+ quantification
- • Cellular energy assessment
- • Aging trajectory analysis
Inflammatory Markers
Key inflammatory cytokines that drive aging and chronic disease[10].
- • IL-11, IL-8, IL-1β
- • TNF-α
- • p21 (cellular senescence)
In Development
Expanding our panel to include comprehensive aging biomarkers.
- • PAI-1, PARC, TARC
- • TNFR1, TNFR2, RAGE
- • MMP1, MPO, RANTES
- • VEGF, ICAM1
Future Panels
Comprehensive health assessment panels coming soon.
- • Insulin resistance markers
- • Mortality risk factors[10]
- • Nutritional factors (vitamins)
- • Environmental toxins[11]
AgeQuant Testing Platform
Our AgeQuant platform leverages cutting-edge analytical technologies to deliver accurate longevity biomarker testing. We're pioneering the use of digital microfluidics[12] alongside traditional methods to dramatically improve testing efficiency and accessibility.
Digital Microfluidics
Revolutionary lab-on-chip technology enabling precise, miniaturized testing[12]
High-Throughput Analysis
Automated workflows and ultra-fast chromatography for rapid results
Lower Testing Barriers
Making advanced biomarker testing accessible and affordable for everyone
Our Vision for Impact
Lower Costs
Digital microfluidics enables dramatic cost reduction in biomarker testing
Key Biomarkers
Currently testing NAD+, IL-11, IL-8, IL-1β, TNF-α, and p21
Full Launch
Expanding to comprehensive longevity panels by 2026
Key Takeaways
- AgeQuant platform democratizes longevity testing with 90% lower costs through digital microfluidics innovation
- Currently testing 6+ key biomarkers including NAD+, inflammatory cytokines (IL-11, IL-8, IL-1β, TNF-α), and cellular senescence marker p21
- First-of-its-kind environmental toxin detection for microplastics and other compounds impacting healthspan
- AI-powered analysis provides personalized health optimization recommendations based on comprehensive biomarker profiles
- Full platform launch in 2026 with expanded panels for metabolic health, mortality risk factors, and nutritional assessment
Scientific References
NAD+ metabolism and the control of energy homeostasis: A balancing act between mitochondria and the nucleus
Cantó C, Menzies KJ, Auwerx J (2015)
Cell Metabolism
Quantification of biological age and frailty with electronic health record data
Searle SD, Mitnitski A, Gahbauer EA, et al. (2008)
BMC Medicine
Microplastics in human blood
Leslie HA, van Velzen MJM, Brandsma SH, et al. (2022)
Environment International